SLC9A3: A Protein with Potential as A Drug Target Or Biomarker

Target Name: SLC9A3

NCBI ID: G6550

SLC9A3

SLC9A3: A Protein with Potential as A Drug Target Or Biomarker

SLC9A3 (MGC126718) is a protein that is expressed in various tissues throughout the body. It is a member of the selective carrier family 9 (SLC9) and is known for its role in the transport of various molecules, including small molecules, ions, and proteins across cell membranes. SLC9A3 has also been shown to play a role in cell signaling, particularly in the regulation of cell adhesion and migration.

One of the unique features of SLC9A3 is its ability to interact with several different signaling pathways, including TGF-β, Wnt, and Notch. SLC9A3 has been shown to be a critical regulator of TGF-β signaling in various tissues, including bone, cartilage , and epithelial cells.

SLC9A3 has also been shown to play a role in the regulation of cell adhesion and migration. For example, SLC9A3 has been shown to be involved in the regulation of tight junction formation in epithelial cells, which is important for the proper functioning of tissues that line the body's surfaces.

In addition to its role in cell signaling, SLC9A3 has also been shown to have several potential drug targets. One of the most promising targets is SLC9A3 itself, as SLC9A3 has been shown to be involved in the regulation of its own expression, which could indicate that it may be a good candidate for a drug target.

Another potential drug target for SLC9A3 is its role in the regulation of cell adhesion and migration. Drugs that are able to disrupt SLC9A3's function in these processes could be effective in treating a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

In addition to its potential drug targets, SLC9A3 also has potential as a biomarker. Its expression has been shown to be associated with a number of diseases, including cancer, neurodegenerative diseases, and developmental disorders. By studying the expression of SLC9A3 in various tissues and conditions, researchers may be able to develop new diagnostic tests or therapeutic approaches for these diseases.

Overall, SLC9A3 is a protein that has the potential to be a drug target or biomarker. Further research is needed to fully understand its role in various tissues and conditions.

Protein Name: Solute Carrier Family 9 Member A3

Functions: Involved in pH regulation to eliminate acids generated by active metabolism or to counter adverse environmental conditions. Major proton extruding system driven by the inward sodium ion chemical gradient (PubMed:26358773). Plays an important role in signal transduction

The "SLC9A3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC9A3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets